Article

Aspheric lens demonstrates night-driving and contrast sensitivity benefits

Results of a prospective, randomized, observer- and subject-masked, contralateral eye study demonstrate benefits of an aspheric IOL (AcrySof IQ model SN60WF, Alcon Laboratories) compared with a spherical single-piece IOL (AcrySof model SA60AT, Alcon Laboratories) for providing better contrast sensitivity and driving performance, said Robert P. Lehmann, MD, a private practitioner in Nacogdoches, TX.

Results of a prospective, randomized, observer- and subject-masked, contralateral eye study demonstrate benefits of an aspheric IOL (AcrySof IQ model SN60WF, Alcon Laboratories) compared with a spherical single-piece IOL (AcrySof model SA60AT, Alcon Laboratories) for providing better contrast sensitivity and driving performance, said Robert P. Lehmann, MD, a private practitioner in Nacogdoches, TX.

The study enrolled 75 patients who were implanted with the aspheric IOL in one eye and the spheric IOL in the fellow eye. A subset of 45 patients underwent contrast sensitivity testing with and without glare using the Functional Acuity Contrast Test viewed through a contrast sensitivity measuring instrument (Optec 6500 Viewer, Stereo Optical). Forty-four of those patients participated in evaluation of night-driving performance using a portable night-driving simulator. All of the testing was performed at a minimum of 3 months after the second eye implantation.

Contrast sensitivity assessment revealed statistically significant differences in favor of the aspheric IOL under mesopic conditions without glare at 3 and 6 cpd. The night-driving tests evaluated detection and identification distances for road warning signs, text signs, and a pedestrian in city and rural scenarios under normal conditions and with glare or fog. The driving performance results consistently demonstrated better performance in eyes with the aspheric IOL and the differences favoring the aspheric IOL eye achieved statistical significance in multiple comparisons. In many of the test situations, the improved stopping times with the aspheric IOL exceeded 0.5 seconds, which is a threshold considered relevant for driving safety.

"These data demonstrate fairly conclusively that the aspheric design of the AcrySof IQ IOL merits not only theoretical but also functional real-world benefits," Dr. Lehmann concluded.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.